Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.

Autor: Schaverien MV; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Singh P; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Smith BD; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston., Akay CL; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Bloom ES; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Chavez-MacGregor M; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Chu CK; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Clemens MW; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Colen JS; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Ehlers RA; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Hwang RF; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Joyner MM; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Largo RD; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Mericli AF; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Mitchell MP; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Shuck JW; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Tamirisa N; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Tripathy D; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Villa MT; Division of Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston., Woodward WA; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Zacharia R; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Kuerer HM; Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Hoffman KE; Division of Radiation Oncology, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e245217. Date of Electronic Publication: 2024 Apr 01.

Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.

Autor: Sammouri J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Venkatesan AM; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: lcolbert@mdanderson.org.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Jan; Vol. 180, pp. 24-34. Date of Electronic Publication: 2023 Dec 01.

Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer.

Autor: Gjyshi O; Department of Radiation Oncology, Saint Elizabeth Cancer Center, Edgewood, KY, United States., Grippin A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Andring L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Bronk J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Sastry JK; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yoshida-Court K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Solley TN; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Napravnik TC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., O'Hara MP; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hegde VL; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2023 Jan 11; Vol. 39, pp. 100578. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).

Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.

Autor: Corrigan KL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yoder A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., De B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu KH; Department of Gynecology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: AKlopp@mdanderson.org.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2022 Mar; Vol. 164 (3), pp. 550-557. Date of Electronic Publication: 2021 Dec 30.

Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis.

Autor: Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Venkatesan AM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Stafford RJ; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX., Bui TP; Department of Anesthesiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Carlson R 3rd; Department of Anesthesiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Bailard NS; Department of Anesthesiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Vedam S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX., Davis R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Olivieri ND; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Guzman AB; Department of Finance, The University of Texas MD Anderson Cancer Center, Houston, TX., Incalcaterra JR; Department of Finance, The University of Texas MD Anderson Cancer Center, Houston, TX., McKelvey FA; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Management, Policy, and Community Health, University of Texas Health Science Center School of Public Health, Houston, TX., Thaker NG; Department of Radiation Oncology, Arizona Oncology, The US Oncology Network, Tucson, AZ., Rauch GM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: aklopp@mdanderson.org.

Publikováno v: Brachytherapy [Brachytherapy] 2020 Jul - Aug; Vol. 19 (4), pp. 427-437. Date of Electronic Publication: 2019 Nov 27.